Roche Expands Diabetes Portfolio


Roche announced the acquisition of Medingo Ltd., a company engaged in the development of a semi-disposable insulin patch pump.
The new Medingo Ltd. micro pump insulin delivery system consists of two parts: a semi-disposable insulin dispensing patch and a remote control, which allows for discreet personalized insulin delivery. It provides the functions of a conventional insulin pump alongside with all advantages of the innovative tubeless patch pump.

The Medingo Ltd. patch pump is not yet marketed. In a next step, production capacities will be scaled-up to prepare for global launch which is expected by 2012.

The acquisition will strengthen Roche Diabetes Care’s position in the fast growing segment of insulin delivery systems.

Notify of
Inline Feedbacks
View all comments
Copyright © 2009-2021 Diabetes Media Foundation, All Rights Reserved.
ASweetLife™ is a trademark of the Diabetes Media Foundation, All Rights Reserved.
Would love your thoughts, please comment.x